Wednesday, April 15, 2020

Biocon Biologics Receives EIR from USFDA for 2 facilities; Biocon gains 2.4%

Biocon's subsidiary, receives EIR from USFDA for two manufacturing facilities, inspection stands closed.

from India Infoline News Service https://ift.tt/2VuN5ZP
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)